Overview

Safety and Efficacy of Combining Intranasal Insulin & Acute Exercise

Status:
Completed
Trial end date:
2020-02-20
Target enrollment:
Participant gender:
Summary
To determine if physical activity engagement alters the dose-response profile and safety of administration of insulin into the intranasal mucosa.
Phase:
Phase 2
Details
Lead Sponsor:
Michigan State University
Treatments:
Insulin
Insulin Aspart
Insulin degludec, insulin aspart drug combination
Insulin, Globin Zinc
Insulin, Long-Acting